Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 USD | -1.41% | +2.03% | +111.45% |
May. 30 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
May. 07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+111.45% | 341M | |
+18.35% | 125B | |
+13.93% | 109B | |
-2.96% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-11.66% | 16.64B | |
-0.07% | 13.45B | |
+22.29% | 11.32B |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- RBC Lifts Price Target on ADC Therapeutics to $8 From $6, 'Encouraged' by Competitive Positioning; Outperform, Speculative Risk Kept